Home / Posts Tagged "Cipla"

On Monday, the companies said in a joint statement that India's Cipla (CIPL.NS) has signed a deal with Eli Lilly (LLY.N) to sell and distribute two of the U.S. drugmaker's best-selling diabetes treatments in the country. The companies said, Lilly will transfer its rights in India to sell, promote

READ MORE

Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in patients who are at high risk* of severe COVID-19 Roche India and Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”) today announced

READ MORE

Strengthens offerings & continues to be at the forefront of COVID care Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”) today announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit ‘ViraGen’ for COVID-19 in India, in partnership with Ubio Biotechnology Systems

READ MORE